Category list : Critical appraisal
Don’t get too excited about ‘female Viagra’ Subscription
FDA succumbs to pressure to approve first agent to treat hypoactive sexual desire disorder in women.
DTB calls on England to reject NHS use of medicines where companies fail to support appraisal process Subscription
England should follow the example of Scotland and Wales and reject the NHS use of medicines where the manufacturer fails to comply with official drug appraisal processes, according to an editorial in the December issue of the Drug and Therapeutics Bulletin (2013;51:133).